Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Alzheimer's Disease; Dementia”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Not Yet RecruitingNCT06177028
What this trial is testing

MCLENA-2: A Phase II Clinical Trial for the Assessment of Lenalidomide in Patients With Mild Cognitive Impairment

Who this might be right for
Cognitive Impairment, MildCognitive DysfunctionAmyloid Plaque+2 more
St. Joseph's Hospital and Medical Center, Phoenix 45
Not applicableStudy completedNCT06708182
What this trial is testing

SAGE LEAF 2: An Online Program to Reduce Dementia Caregiver Burden

Who this might be right for
Caregiving StressCaregiver Burden
Northwestern University 53
Testing effectiveness (Phase 2)Ended earlyNCT03919162
What this trial is testing

A Trial to Evaluate the Efficacy and Safety of PQ912 in Patients With Early AD

Who this might be right for
Alzheimer Disease
Vivoryon Therapeutics N.V. 112
Not applicableStudy completedNCT03224988
What this trial is testing

Bilateral Brain Dynamics in Cognition and Aging

Who this might be right for
Alzheimer DiseaseAgingMCI
Duke University 30
Not applicableLooking for participantsNCT07117162
What this trial is testing

Improving Access to Care for Veterans With Memory Loss

Who this might be right for
Alzheimer Disease
VA Pittsburgh Healthcare System 30
Not applicableLooking for participantsNCT07425769
What this trial is testing

Adapting RDAD for DS

Who this might be right for
Down Syndrome (DS)Alzheimer's Disease (AD)
University of Kansas Medical Center 40
Not applicableStudy completedNCT03532269
What this trial is testing

Validation of the Sleep Assessment Algorithm in the Medical Application Nightly

Who this might be right for
Sleep DisorderNightmare
DreamJay Sp. z o. o. 30
Testing effectiveness (Phase 2)Ended earlyNCT00087724
What this trial is testing

Study to Evaluate FK962 in Subjects With Mild to Moderate Alzheimer's Disease

Who this might be right for
Alzheimer's Disease
Astellas Pharma Inc 510
Large-scale testing (Phase 3)Study completedNCT01028053
What this trial is testing

Assess the Prognostic Usefulness of Flutemetamol (18F) Injection for Identifying Subjects With Amnestic Mild Cognitive Impairment Who Will Convert to Clinically Probable Alzheimer's Disease

Who this might be right for
Mild Cognitive ImpairmentAlzheimer's Disease
GE Healthcare 365
Early research (Phase 1)Study completedNCT01168245
What this trial is testing

TMS Stimulation and Cognitive Training in Alzheimer Patients

Who this might be right for
Alzheimer DiseaseMild to Moderate
Neuronix Ltd 15
Large-scale testing (Phase 3)UnknownNCT01867775
What this trial is testing

Mirtazapine for Sleep Disorders in Alzheimer's Disease

Who this might be right for
Alzheimer's DiseaseSleep Disorders
Brasilia University Hospital 30
Testing effectiveness (Phase 2)Study completedNCT05323812
What this trial is testing

ASURE: Alzheimer Study Using oRal Edaravone

Who this might be right for
Alzheimer Disease
Treeway B.V. 61
Early research (Phase 1)Study completedNCT03277573
What this trial is testing

Salsalate in Patients Mild to Moderate Alzheimer's Disease

Who this might be right for
Alzheimer Disease
Adam Boxer 40
Not applicableNot Yet RecruitingNCT07631247
What this trial is testing

IPath for CP Pilot

Who this might be right for
Depression - Major Depressive Disorder
Dartmouth-Hitchcock Medical Center 15
Not applicableUnknownNCT01128725
What this trial is testing

Truncated and Extended Forms of Amyloid Beta Peptides in Alzheimer's Disease: Genesis, Toxicity and Identification as Biological Markers

Who this might be right for
Alzheimer Disease
Centre Hospitalier Universitaire de Nice 100
Very early researchStudy completedNCT03587376
What this trial is testing

Characterization of T-Cell Response in Participants Previously Treated With JNJ-54861911 (Atabecestat)

Who this might be right for
Alzheimer Disease
Janssen Research & Development, LLC 9
Large-scale testing (Phase 3)Ended earlyNCT02484547
What this trial is testing

221AD302 Phase 3 Study of Aducanumab (BIIB037) in Early Alzheimer's Disease

Who this might be right for
Alzheimer's Disease
Biogen 1,643
Not applicableLooking for participantsNCT07006155
What this trial is testing

Biograph Vision 600 Versus Biograph Vision.X PET/CT

Who this might be right for
CancerAlzheimer Disease
Valentina Garibotto 40
Testing effectiveness (Phase 2)UnknownNCT04169126
What this trial is testing

Topography Staging and Dual Phase Image Quantification of Tau PET in Cognitive Impairment Subjects

Who this might be right for
Alzheimer's Disease
Chang Gung Memorial Hospital 300
Testing effectiveness (Phase 2)Study completedNCT02707458
What this trial is testing

Dosage and Efficacy of Probucol-induced apoE to Negate Cognitive Deterioration

Who this might be right for
Dementia of the Alzheimer TypeAge-related Cognitive DeclineMild Cognitive Impairment Due to Alzheimer Disease
Douglas Mental Health University Institute 23
Next Page